oral characteristics
Showing 1 - 25 of >10,000
Gastro Esophageal Reflux Trial (Lansoprazole 15 mg, Lansoprazole 15mg/Calcium carbonate 600mg)
Not yet recruiting
- Gastro Esophageal Reflux
- Lansoprazole 15 mg
- Lansoprazole 15mg/Calcium carbonate 600mg
- (no location specified)
Sep 3, 2023
Chronic HBV Infection Trial in Chongqing (PA3670)
Recruiting
- Chronic HBV Infection
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
May 6, 2023
Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)
Completed
- Healthy Subject
- Ursodeoxycholic Acid 250 Mg Oral Tablet
-
Seoul, Korea, Republic Of, Korea, Democratic People's Republic ofKyung Hee University Medical Hospital
Apr 16, 2023
Nutrition, Physical Activity, Mediterranean Diet Adherence, and
Recruiting
- Diet Habit
- +3 more
-
Ankara, TurkeyAnkara Medipol University Oral and Dental Health Practice and Re
Nov 11, 2023
Oxygen Saturation, Heart Rate, Nutritional Status Trial in Istanbul (Cup feeding, Bottle feeding)
Completed
- Oxygen Saturation
- +2 more
- Cup feeding
- Bottle feeding
-
Istanbul, TurkeyIstanbul University, Cerrahpaşa
Jan 4, 2023
Diabetes, Type 2 Trial in Seoul (HGR4113, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- HGR4113
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 30, 2022
Influenza, Human Trial in Shanghai (ZX-7101A 80mg)
Recruiting
- Influenza, Human
- ZX-7101A 80mg
-
Shanghai, ChinaShuguang Hospital, Shanghai University of Traditional Chinese Me
Feb 2, 2023
Commonly Consumed Foods
Completed
- Adults
- Ad libitum energy intake
-
Singapore, SingaporeSingapore Institute of Food and Biotechnology Innovation (SIFBI)
Dec 13, 2021
Hypertension Trial (CKD-341, D958)
Not yet recruiting
- Hypertension
- CKD-341, D958
- (no location specified)
Jun 18, 2023
Oral Processing Characteristics of Commonly Consumed Meals
Recruiting
- Adults
- Ad libitum energy intake
-
Singapore, SingaporeSingapore Institute of Food and Biotechnology Innovation (SIFBI)
Nov 24, 2021
Oral Anticoagulants in Italian Elderly Non-Valvular Atrial
Recruiting
- Non-Valvular Atrial Fibrillation (NVAF)
-
Milano, MI, ItalyEcol Studio SpA
Jan 31, 2022
Oral Lesions Trial in Houston (High Resolution Microendoscope (HRME), Optical Mapping Scope, Proflavine hemisulfate)
Not yet recruiting
- Oral Lesions
- High Resolution Microendoscope (HRME)
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Healthy Subjects Trial in Shanghai (Deuremidevir Hydrobromide for Suspension 100mg, Deuremidevir Hydrobromide for Suspension
Not yet recruiting
- Healthy Subjects
- Deuremidevir Hydrobromide for Suspension 100mg
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Jun 30, 2023
Obesity Trial in Seoul (HSG4112, Placebo)
Recruiting
- Obesity
- HSG4112
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 27, 2022
Tobacco Use Disorder, Oral Nicotine Pouch Use, Smoking Behaviors Trial in New Haven (ZYN)
Completed
- Tobacco Use Disorder
- +5 more
- ZYN
-
New Haven, ConnecticutYale University
Oct 24, 2022
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum Trial (Medical nutrition)
Completed
- Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
- Medical nutrition
- (no location specified)
Aug 4, 2022
Gingivitis, Periodontitis Trial (Periodontal examination, baseline questionnaire about sociodemographic characteristics, smoking
Not yet recruiting
- Gingivitis
- Periodontitis
- Periodontal examination
- +4 more
- (no location specified)
Oct 4, 2023
Gastritis Trial in Cheongju-si (DW1903, DW1903-R1, DW1903-R2)
Completed
- Gastritis
- DW1903
- +2 more
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Dec 10, 2021
Dental Caries Trial in Shijiazhuang (Lactobacillus rhamnosus X253)
Completed
- Dental Caries
- Lactobacillus rhamnosus X253
-
Shijiazhuang, Hebei, ChinaShijiazhuang JunlebaoDairy Co.Ltd.
Nov 9, 2021
Healthy Trial in Nanjing (GB001 recombinant peptide spray, Placebo)
Active, not recruiting
- Healthy
- GB001 recombinant peptide spray
- Placebo
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing medical University
Dec 1, 2022
Periodontal Assessment of a Bariatric Care Population
Active, not recruiting
- Bariatric Surgery Candidate
- Obesity
-
London, United Kingdom
- +1 more
Sep 12, 2022
Prediction for Critical Outcomes of Patients With COVID-19
Active, not recruiting
- Prediction Model
- +3 more
- No intervention group
-
Alkmaar, Netherlands
- +1 more
Nov 17, 2021